Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CP✓SelectedUSD · CPMRNA vs CP performance historyLatest closeAs of-3.45%11/13
Stock and ETF performance explorer

MRNA vs CP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,100.9%
CP return
+153.9%
Excess return
+947.0%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCPExcessAlpha
1D-3.4%-0.5%-3.0%-3.3%
7D-12.1%+2.1%-14.3%-12.6%
30D-1.3%+9.3%-10.6%-3.8%
3M+250.9%+0.5%+250.5%+250.2%
6M+343.0%+10.4%+332.6%+329.3%
YTD+657.4%+28.7%+628.7%+601.8%
1Y+794.9%+33.2%+761.7%+721.9%
3Y+218.1%+38.4%+179.7%+196.5%
5Y-3.4%+26.2%-29.6%-9.4%
All+1,100.9%+153.9%+947.0%+893.4%

Cumulative growth

Daily Returns

Daily percentage return beside CP.

Daily Out/Under-Performance

Portfolio return minus CP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling